Home › Cervical Cancer › Florida › Sarasota
Cervical Cancer clinical trials in Sarasota, FL
4 studies for Cervical Cancer are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- Florida Cancer Specialists, Sarasota
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- Sarasota Memorial Health Care System, Sarasota
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RecruitingPhase 1
- SCRI FCS Sarasota, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Sarasota
About Cervical Cancer
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
More about Cervical Cancer on MedlinePlus
Cervical Cancer trials in other cities
- Houston, TX34 studies
- New York City, NY20 studies
- Nashville, TN19 studies
- Boston, MA19 studies
- Arlington, VA18 studies
- Los Angeles, CA17 studies
- San Antonio, TX14 studies
- Dallas, TX14 studies
- St. Louis, MO12 studies
- Orlando, FL12 studies
- Columbus, OH12 studies
- Baldwin Park, CA11 studies
Other studies in Sarasota
- Metastatic Cancer17 studies
- Non-Small Cell Lung Cancer17 studies
- Colorectal Cancer15 studies
- Ovarian Cancer14 studies
- Breast Cancer12 studies
- Endometrial Cancer12 studies
- Cancer (all types)10 studies
- Triple-Negative Breast Cancer8 studies
- Lung Cancer8 studies
- Pancreatic Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Atrial Fibrillation6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.